Fidelity Advisor Biotechnology Fund
Fidelity Advisor Biotechnology Fund
Fund · US3159184908 · FBTTX (XNAS)
Overview
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 7,81 % -0,62 %

Company Profile for Fidelity Advisor Biotechnology Fund Fund

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

Company Data

Name Fidelity Advisor Biotechnology Fund
Company Fidelity Advisor Biotechnology Fund
Symbol FBTTX
Primary Exchange XNAS NASDAQ
ISIN US3159184908
Asset Class Fund
Sector Financial Services
Industry Asset Management
Market Capitalization 1 Mrd.
Country United States of America
Currency USD
Employees -
Address Fidelity Advisor Series VII,
IPO Date 2000-12-27
Dividends from 'Fidelity Advisor Biotechnology Fund'
Ex-Date Dividend per Share
21.12.2023 0,23 USD
17.12.2021 0,07 USD
09.07.2021 0,07 USD
18.12.2020 2,78 USD
20.12.2019 1,85 USD
07.12.2018 0,59 USD
11.09.2015 1,35 USD
12.12.2014 0,42 USD
05.09.2014 0,18 USD
13.12.2013 0,05 USD

Ticker Symbols

Name Symbol
NASDAQ FBTTX

More Shares

Investors who Fidelity Advisor Biotechnology Fund hold also have the following shares in their portfolio:
GRIECHENLAND 20/30
GRIECHENLAND 20/30 Bond
RENEGADE GOLD INC.
RENEGADE GOLD INC. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025